Serum monoclonal component in chronic lymphocytic leukemia: baseline correlations and prognostic impact

Pablo Mozas; Juan A Pineyroa; Ferran Nadeu; Laura Magnano; Andrea Rivero; Alfredo Rivas-Delgado; Alex Bataller; Aleix Fabregat; Eva Gine; Tycho Baumann; Neus Villamor; Juan Ignacio Arostegui; Marta Aymerich; Armando Lopez-Guillermo; Elias Campo; Julio Delgado

doi:10.3324/haematol.2020.263228

Serum monoclonal component in chronic lymphocytic leukemia: baseline correlations and prognostic impact

Haematologica. 2021 Jun 1;106(6):1754-1757. doi: 10.3324/haematol.2020.263228.

Authors

Pablo Mozas¹, Juan A Pineyroa¹, Ferran Nadeu², Laura Magnano³, Andrea Rivero¹, Alfredo Rivas-Delgado¹, Alex Bataller¹, Aleix Fabregat⁴, Eva Gine⁵, Tycho Baumann¹, Neus Villamor⁶, Juan Ignacio Arostegui⁷, Marta Aymerich⁸, Armando Lopez-Guillermo⁹, Elias Campo¹⁰, Julio Delgado¹¹

Affiliations

¹ Department of Hematology, Hospital Clínic, Barcelona.
² Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid.
³ Department of Hematology, Hospital Clínic, Barcelona, Spain; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona.
⁴ Department of Biochemistry and Molecular Biology, Hospital Clínic, Barcelona.
⁵ Department of Hematology, Hospital Clínic, Barcelona, Spain; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid.
⁶ Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain; Hematopathology Unit, Department of Pathology, Hospital Clínic, Barcelona.
⁷ Department of Immunology, Hospital Clínic, Barcelona.
⁸ Hematopathology Unit, Department of Pathology, Hospital Clínic, Barcelona.
⁹ Department of Hematology, Hospital Clínic, Barcelona, Spain; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain; Universitat de Barcelona.
¹⁰ Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain; Hematopathology Unit, Department of Pathology, Hospital Clínic, Barcelona, Spain; Universitat de Barcelona.
¹¹ Department of Hematology, Hospital Clínic, Barcelona, Spain; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid.

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Biomarkers, Tumor
Humans
Leukemia, Lymphocytic, Chronic, B-Cell* / diagnosis
Prognosis

Substances

Biomarkers, Tumor

Grants and funding

Funding: this study was supported by “Becas de Investigación de la FEHH” (Fundación Española de Hematología y Hemoterapia) to PM; FN received a pre-doctoral fellowship of the Ministerio de Economía y Competitividad (MINECO, BES-2016-076372); LM received the PI19/00925 grant (Instituto de Salud Carlos III); AL-G and EG received the PI19/00887 grant (Instituto de Salud Carlos III); EC is supported by grants from “La Caixa” Foundation (CLLEvolution- LCF/PR/HR17/52150017), the Instituto de Salud Carlos III, the European Regional Development Fund (FEDER – “Una Manera de Hacer Europa”) (PMP15/00007), and is an Academia Researcher of the Institució Catalana de Recerca i Estudis Avançats (ICREA) of the Generalitat de Catalunya.